Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction

Does Age at Operation Influence the Short- and Long-Term Outcomes of Off-Pump Coronary Artery Bypass Grafting?

“…15,20,21 These complications result from aortic manipulation, embolic complications, non-physiological circulation, cardiac arrest, coagulation disturbances, and systemic inflammation. 9-11,14, 22 Stamou et al demonstrated that the benefits of OPCAB are more evident in high-risk patients based on short-and long-term results. 9 The report from The Society of Thoracic Surgeons National Clinical Database demonstrated that OPCAB significantly reduces the risk of death, stroke, and acute renal failure.…”

The impact of viability assessment using myocardial perfusion imaging on patient management and outcome

“…The extent of resting ischemia was small in our patients similar to the degree of flow-metabolism mismatch in the study by Beanlands et al 20 Both prior CABG and a history of ventricular arrhythmias favored MT over CR because of the known additional risk. [28][29][30] Another important factor that weighed in favor of proceeding with CR in our cohort was the presence of chest pain. The Coronary Artery Surgery Study showed a survival benefit for CABG in patients with depressed LVEF, this benefit was limited to patients who were symptomatic with chest pain.…”

Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging–Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease

“…1,2 There is a large body of predominantly observational data to demonstrate that restoration of blood flow to dysfunctional myocardium in the territory of a stenosed coronary artery is beneficial, [3][4][5] but controversies remain regarding surgical revascularization, Background-Whether viability imaging can impact long-term patient outcomes is uncertain. The PARR-2 study (Positron Emission Tomography and Recovery Following Revascularization) showed a nonsignificant trend toward improved outcomes at 1 year using an F-18-fluorodeoxyglucose positron emission tomography (PET)-assisted strategy in patients with suspected ischemic cardiomyopathy.…”